Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety Study of a IMSS Developed Phytopharmaceutical for the Treatment of Anxiety. Double Blind and Randomized Clinical Trial Controlled With Alprazolam

NCT03702803 is registered in ClinicalTrials.gov with Coordinación de Investigación en Salud, Mexico as lead sponsor.

NCT NCT03702803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03702803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety Study of a IMSS Developed Phytopharmaceutical for the Treatment of Anxiety. Double Blind and Randomized Clinical Trial Controlled With Alprazolam
Lead sponsor
Coordinación de Investigación en Salud, Mexico
Phase
Phase 2
Overall status
Unknown status
Start date
March 16, 2016
Completion date
October 19, 2020
Enrollment
122 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

generalized anxiety disorder